Currently Viewing:
National Association of ACOs Fall 2018
Dr Joe Antos: CMS' Proposed MSSP Changes Don't Account for Variability in Healthcare
October 04, 2018
Innovative Strategies Can Boost ACO Provider Engagement, Performance
October 05, 2018
Tying Social Determinants of ACO Patients With High-Need, High-Cost Care
October 05, 2018
Dr Clif Gaus Highlights Excitement and Anxiety at NAACOS Fall 2018 Meeting
October 06, 2018
Dr Rob Fields Discusses How the Proposed MSSP Changes Impact Decisions Around ACOs
October 08, 2018
Predictability and Simplicity Needed to Help ACOs Take on Risk, Panelists Say at NAACOS
October 08, 2018
Are Commercial Payers Experiencing Success With ACO Partnerships?
October 08, 2018
Dr Katherine Schneider on Handling Variability in ACO Contracts
October 10, 2018
Stephen Nuckolls: 2 Years Isn't Enough Time for an ACO to Take on Risk
October 14, 2018
Dr Clif Gaus: Private Payer Engagement in ACOs Is Up
October 15, 2018
Allison Brennan: Trump's Administration Is Encouraging Risk, but Possibly Too Quickly
October 16, 2018
Dr Joe Antos: Proposed MSSP Changes Not a Major Shift in Policy for ACOs
October 18, 2018
Currently Reading
Dr Rob Fields Discusses Why More ACOs Might Turn to Medicare Advantage
October 21, 2018
Dr Katherine Schneider Highlights How Proposed MSSP Changes Build Stability Into Program
October 27, 2018
Allison Brennan Highlights Areas of Opportunity With Proposed MSSP Changes
October 28, 2018
Dr Rob Fields: Proposed MSSP Changes Likely to Stifle ACO Movement, Increase Consolidation
October 30, 2018
Dr Clif Gaus Discusses Measuring MSSP ACOs Savings
October 31, 2018
Dr Joe Antos: Attention Needs to Be on the Future Sustainability of Medicare
November 03, 2018
Dr Katherine Schneider: MSSP Proposed Changes Will Be a Step Back on Path to Value
November 07, 2018
Stephen Nuckolls Discusses What May Change Under the Proposed Pathways to Success
November 10, 2018
Allison Brennan Outlines the Greatest Challenges of the Proposed MSSP Changes
November 11, 2018
Dr Rob Fields Highlights Areas for Continued Innovation With ACOs
November 17, 2018
Dr Joe Antos Dissects the Challenge of Addressing Drug Prices
November 23, 2018
Allison Brennan Discusses Impacts of Certain Proposed Changes to the MSSP
November 24, 2018

Dr Rob Fields Discusses Why More ACOs Might Turn to Medicare Advantage

The push to get accountable care organizations to take on risk faster could lead to more participation in Medicare Advantage, said Rob Fields, MD, assistant profession, family medicine and community health, Icahn School of Medicine at Mount Sinai, and senior vice president, chief medical officer, population health at Mount Sinai Health System.


The push to get accountable care organizations to take on risk faster could lead to more participation in Medicare Advantage, said Rob Fields, MD, assistant profession, family medicine and community health, Icahn School of Medicine at Mount Sinai, and senior vice president, chief medical officer, population health at Mount Sinai Health System.

Transcript

With the proposed changes to MSSP, could we see more commercial ACO contracts?

I certainly think we’ll see a growth and a continued movement toward Medicare Advantage, certainly in the world of value. And I say that because for systems that are working in this space, the rules around how Medicare Advantage risk works compared to the Medicare fee-for-service value tracks, the rules are a lot fairer in Medicare Advantage. It’s easier to get the business operations in line with the clinical operations in Medicare Advantage.

So, while that shift already occurs, there are certainly many systems that have taken a Medicare Advantage-only approach, I think that will only get worse. Meaning: a lot more Medicare Advantage and, perhaps, less concentration on regular fee-for-service value contracts. Just because the rules will be too difficult to navigate.

Research has shown that ACOs that have been doing it longer, do better. Is the proposed 2-year timeline to take on risk in MSSP enough time to get it right?

I think the data is really clear that 2 years is probably not enough, that it takes somewhere in the neighborhood of 3 to 4 years to see a system start to perform under these value-based arrangements. Two years, frankly, feels somewhat arbitrary, and not really demonstrating what the data would show.

I do think it’s going to be a problem and leads to the idea that I think it would be difficult for new ACOs that have not been in this space before. You don’t just wake up one day knowing how to take on value and how to take on risk and how to do this kind of work. It takes some time. And we know, actually at this point, how much time it kind of takes for most systems. So, it would be, I think, somewhat more helpful and more effective to design the rule and the path toward risk to be in line with what, actually, the data shows.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!